OMIC - Singular Genomics Systems, Inc.
IEX Last Trade
19.36
2.330 12.035%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:21:27 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$17.03
2.33
13.68%
Fundamental analysis
20%
Profitability
0%
Dept financing
9%
Liquidity
75%
Performance
30%
Performance
5 Days
-1.02%
1 Month
-9.45%
3 Months
22.78%
6 Months
122.41%
1 Year
50.35%
2 Year
-70.95%
Key data
Stock price
$19.36
DAY RANGE
$17.03 - $19.66
52 WEEK RANGE
$5.75 - $23.41
52 WEEK CHANGE
$44.62
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
Company detail
CEO: Andrew Spaventa
Region: US
Website: singulargenomics.com
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: singulargenomics.com
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology. The company manufactures G4 Instrument, a benchtop next generation sequencer, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument.
Recent news